Circadian Therapeutics Announce the Appointment of Dr. Mark Sampson Circadian Therapeutics Ltd is delighted to announce the appointment of Dr Mark Sampson as Chief Executive Officer and Board Member of the Company, effective 1st July 2020. Most recently Chief Medical...
Study Links Exposure to Light at Night to Depression Researchers at the Nara Medical University School of Medicine in Nara, Japan, performed a two year study on 863 subjects. The study found that the link between light exposure and depression occurred even when the...
Collaboration with Blind Veterans UK The launch of our exciting research collaboration with the Blind Veterans UK Charity. Nigel Jones, Managing Director and COO of Circadian Therapeutics (CT) is pictured signing the research collaboration agreement with Major General...
Study Underlines Increased Cancer Risk for Women Night Workers Due to Circadian Rhythm Disruption The “Journal Cancer Epidemiology, Biomarkers and Prevention” recently published a meta-analysis of 61 previous studies concluding that long-term night shift work among...
Circadian Rhythm Disruption Linked to Alzheimer’s Research at Washington University School of Medicine in St. Louis, published in the “JAMA Neurology” journal, indicates that circadian rhythm disruptions occur much earlier in people whose memories are intact but whose...